Efficacy and Safety of 5-week and 2-week Neoadjuvant Chemoradiotherapy in Treatment of Resectable and Borderline Resectable Pancreatic Cancer

WANG?Junsong

doi:10.3969/j.issn.1672-7185.2022.10.019

Home>Articles>Efficacy and Safety of 5-week and 2-week Neoadjuvant Chemoradiotherapy in Treatment of Resectable and Borderline Resectable Pancreatic Cancer

DOI: 10.3969/j.issn.1672-7185.2022.10.019

Efficacy and Safety of 5-week and 2-week Neoadjuvant Chemoradiotherapy in Treatment of Resectable and Borderline Resectable Pancreatic Cancer

WANG?Junsong

Machine-generated Keywords：

Publication Date：2022-10-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 58-62 )

Chinese Practical Journal of Rural Doctor

ISSN：1672-7185

Year, Vol.(Issue)：2022,29(10)